First-line pembrolizumab (pembro) plus chemotherapy (chemo) for advanced esophageal cancer: 5-year outcomes from the phase 3 KEYNOTE-590 study.

Autor: Shah, Manish A., Sun, Jong-Mu, Shen, Lin, Kato, Ken, Enzinger, Peter C., Adenis, Antoine, Doi, Toshihiko, Kojima, Takashi, Li, Zhigang, Kim, Sung-Bae, Cho, Byoung Chul, Mansoor, Wasat, Li, Shau-Hsuan, Sunpaweravong, Patrapim, Alsina Maqueda, Maria, Buchschacher, Gary L, Wu, Jimin, Shah, Sukrut, Bhagia, Pooja, Metges, Jean-Philippe

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p250-250, 185p

ICO-ICS Praxi per al tractament mèdic i amb irradiació de càncer gàstric i d'unió esofagogàstrica

Autor: Alsina Maqueda, Maria, Boladeras Inglada, Anna M., Bugès Sanchez, Cristina, Calvo-Campos, Mariona, Canals-Subirats, Eugeni, Caro-Gallarín, Mònica, Creus Costas, Glòria, Fort-Casamartina, Eduard, Galán Guzmán, Maica, Gilabert-Sotoca, Marta, Guardeño Sánchez, Raquel, Guerra-Prió, Silvia, Hormigo Rubio, Glòria, Lezcano-Rubio, Clara, Mira-Flores, Moisés J., Navalpotro, Begoña, Serra-Solé, Òlbia, Tuset Der-Abrain, Noemí, Valdivia Vadell, Carolina, Virgili Casas, Núria

Publikováno v: Scientia

Tractament mèdic; Tractament amb irradiació; Càncer de la unió esofagogàstrica Tratamiento médico; Tratamiento con irradiación; Cáncer de la unión esofagogástrica Medical treatment; Irradiation treatment; Esophagogastric union cancer El cà

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3991::a1cc67e57fe875e93ac296c81c0b5834
https://hdl.handle.net/11351/6061

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Autor: Shitara, Kohei, Özgüroğlu, Mustafa, Bang, Yung-Jue, Di Bartolomeo, Maria, Mandalà, Mario, Ryu, Min-Hee, Fornaro, Lorenzo, Olesiński, Tomasz, Caglevic, Christian, Chung, Hyun C, Muro, Kei, Goekkurt, Eray, Mansoor, Wasat, McDermott, Raymond S, Shacham-Shmueli, Einat, Chen, Xinqun, Mayo, Carlos, Kang, S Peter, Ohtsu, Atsushi, Fuchs, Charles S, Lerzo, Guillermo, O'Connor, Juan Manuel, Mendez, Guillermo Ariel, Lynam, James, Tebbutt, Niall, Wong, Mark, Strickland, Andrew, Karapetis, Chris, Goldstein, David, Vasey, Paul, Van Laethem, Jean-Luc, Van Cutsem, Eric, Berry, Scott, Vincent, Mark, Muller, Bettina, Rey, Felipe, Zambrano, Angela, Guerra, Joaquin, Krogh, Merete, Baeksgaard, Lene, Yilmaz, Mette, Elme, Anneli, Magi, Andrus, Auvinen, Paivi, Alanko, Tuomo, Moehler, Markus, Kunzmann, Volker, Seufferlein, Thomas, Thuss-Patience, Peter, Goekkurt, Eray, Hoehler, Thomas, Haag, Georg, Al-Batran, Salah-Eddin, Castro, Hugo, Lopez, Karla, Aguilar Vasquez, Mynor, Sandoval, Mario, Lam, Ka On, Cuffe, Sinead, Kelly, Cathy, Geva, Ravit, Shacham-Shmueli, Einat, Hubert, Ayala, Beny, Alex, Brenner, Baruch, Giuseppe, Aprile, Falcone, Alfredo, Maiello, Evaristo, Passalacqua, Rodolfo, Montesarchio, Vincenzo, Hara, Hiroki, Chin, Keisho, Nishina, Tomohiro, Komatsu, Yoshito, Machida, Nozumo, Hironaka, Shuichi, Satoh, Taroh, Tamura, Takao, Sugimoto, Naotaoshi, Cho, Haruhiko, Omuro, Yashushi, Kato, Ken, Goto, Masahiro, Hyodo, Ichinosuke, Yoshida, Kazuhiro, Baba, Hideo, Esaki, Taito, Furuse, Junji, Wan Mohammed, Wan Zamaniah, Hernandez Hernandez, Carlos, Casas Garcia, Juan, Dominguez Andrade, Adriana, Clarke, Katriona, Hjortland, Geir, Glenjen, Nils, Kubiatowski, Tomasz, Jacek, Jassem, Wojtukiewicz, Marek, Lazarev, Sergey, Lancukhay, Yuri, Afanasayev, Sergey, Moiseyenko, Vladimir, Kostorov, Vladimir, Protsenko, Svetlana, Shirinkin, Vadim, Sakaeva, Dina, Fadeeva, Natalia, Yong, Wei Peng, Ng, Chau Hsien Matthew, Robertson, Barbara, Rapaport, Bernardo, Cohen, Graham, Dreosti, Lydia, Ruff, Paul, Jacobs, Conrad, Landers, Gregory, Szpak, Waldemar, Roh, Sang-Young, Lee, Jeeyun, Kim, Yeul Hong, Bang, Yung-Jue, Chung, Hyun Cheol, Ryu, Min-Hee, Alsina Maqueda, Maria, Longo Munoz, Federico, Cervantes Aguilar, Andres, Aranda Aguilar, Enrique, Garcia Alfonso, Pilar, Rivera, Fernando, Feliu Batle, Jaime, Pazo Cid, Roberto, Yeh, Kun-Huei, Chen, Jen-Shi, Chao, Yee, Yen, Chia-Jui, Özgüroğlu, Mustafa, Kara, Oguz, Yalcin, Suayib, Hochhauser, Daniel, Chau, Ian, Benson, Al, Shankaran, Veena, Shaib, Walid, Philip, Philip, Sharma, Vivek, Siegel, Robert, Sun, Weijing, Wainberg, Zev, George, Ben, Bullock, Andrea, Myrick, Samuel, Faruol, Josephine, Siegel, Richard, Larson, Timothy, Becerra, Carlos, Ratnam, Suresh, Richards, Donald A., Riche, Stephen L.

Publikováno v: The Lancet; July 2018, Vol. 392 Issue: 10142 p123-133, 11p

Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.

Autor: Ko AH; Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Kim KP; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Siveke JT; Department of Medical Oncology and Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK/DKFZ, partner site Essen), West German Cancer Center, University Hospital Essen, Essen, Germany., Lopez CD; Division of Hematology Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR, USA., Lacy J; Department of Medicine, Section of Medical Oncology, Yale School of Medicine, Yale University, New Haven, CT, USA., O'Reilly EM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Macarulla T; Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Manji GA; Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, USA., Lee J; Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Ajani J; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alsina Maqueda M; Gastrointestinal Cancer Unit, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Rha SY; Department of Internal Medicine, Yonsei Cancer Center, Yonsei University Health System, Seoul, Republic of Korea., Lau J; Genentech, Inc., South San Francisco, CA, USA., Al-Sakaff N; F. Hoffmann-La Roche, Ltd, Basel, Switzerland., Allen S; Genentech, Inc., South San Francisco, CA, USA., Lu D; Hoffmann-La Roche Limited, Mississauga, ON, Canada., Shemesh CS; Genentech, Inc., South San Francisco, CA, USA., Gan X; Product Development Safety, Roche (China) Holding Ltd, Shanghai, People's Republic of China., Cha E; Genentech, Inc., South San Francisco, CA, USA., Oh DY; Department of Internal Medicine, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.; Integrated Major in Innovative Medical Science, Seoul National University Graduate School, Seoul, Republic of Korea.

Publikováno v: The oncologist [Oncologist] 2023 Jun 02; Vol. 28 (6), pp. 553-e472.